Loss of SFRP1 Expression is Associated with Aberrant β-Catenin Distribution and Tumor Progression in Mucoepidermoid Carcinoma of Salivary Glands

被引:0
|
作者
Chien-Hsing Lee
Yi-Jen Hung
Chih-Yuan Lin
Pei-Hsin Hung
Hsing-Wen Hung
Yi-Shing Shieh
机构
[1] National Defense Medical Center,Graduate Institute of Medical Sciences
[2] Tri-Service General Hospital,Departments of Internal Medicine
[3] Tri-Service General Hospital,Departments of Surgery
[4] Tri-Service General Hospital,Departments of Dentistry
[5] National Defense Medical Center,School of Dentistry
来源
Annals of Surgical Oncology | 2010年 / 17卷
关键词
Methylation Status; Adenomatous Polyposis Coli; Mucoepidermoid Carcinoma; Ethylene Glycol Tetraacetic Acid; Noncancerous Tissue;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2237 / 2246
页数:9
相关论文
共 50 条
  • [21] Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma
    Wei Guo
    Zhiming Dong
    Yanli Guo
    Xinwen Lin
    Zhifeng Chen
    Gang Kuang
    Zhibin Yang
    Clinical & Experimental Metastasis, 2013, 30 : 265 - 275
  • [22] Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma
    Guo, Wei
    Dong, Zhiming
    Guo, Yanli
    Lin, Xinwen
    Chen, Zhifeng
    Kuang, Gang
    Yang, Zhibin
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (03) : 265 - 275
  • [23] β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma:: Its role in cyclin D1 overexpression and tumor progression
    Shiratsuchi, Hideki
    Nakashima, Torahiko
    Hirakawa, Naoya
    Toh, Satoshi
    Nakagawa, Takashi
    Saito, Tsuyoshi
    Tsuneyoshi, Masazumi
    Komune, Shizuo
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (06): : 577 - 584
  • [24] WNT pathway and mammary carcinogenesis:: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
    Ugolini, F
    Charafe-Jauffret, E
    Bardou, VJ
    Geneix, J
    Adélaïde, J
    Labat-Moleur, F
    Penault-Llorca, F
    Longy, M
    Jacquemier, J
    Birnbaum, D
    Pébusque, MJ
    ONCOGENE, 2001, 20 (41) : 5810 - 5817
  • [25] WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
    Françoise Ugolini
    Emmanuelle Charafe-Jauffret
    Valérie-Jeanne Bardou
    Jeannine Geneix
    José Adélaïde
    Françoise Labat-Moleur
    Frédérique Penault-Llorca
    Michel Longy
    Jocelyne Jacquemier
    Daniel Birnbaum
    Marie-Josèphe Pébusque
    Oncogene, 2001, 20 : 5810 - 5817
  • [26] Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: Correlation with vascular endothelial growth factor, microvessel density, and clinical outcome
    Shi, Lu
    Chen, Xin-Ming
    Wang, Li
    Zhang, Lu
    Chen, Zhi
    CANCER, 2007, 109 (08) : 1523 - 1531
  • [27] Novel expression profile of the Wnt inhibitor Secreted Frizzled-Related Protein 1 (SFRP1) in endometrial carcinoma-A potential role as marker of progression
    Dellinger, T. H.
    Planutis, K.
    Monk, B. J.
    Holcombe, R. F.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 433 - 434
  • [28] The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo
    Jin, Xuewen
    Liu, Yuling
    Liu, Jingjing
    Lu, Weiliang
    Liang, Ziwei
    Zhang, Dan
    Liu, Gang
    Zhu, Hongxia
    Xu, Ningzhi
    Liang, Shufang
    PLOS ONE, 2015, 10 (08):
  • [29] LINC00092 Suppresses the Malignant Progression of Breast Invasive Ductal Carcinoma Through Modulating SFRP1 Expression by Sponging miR-1827
    Zhao, Chun-Ming
    Li, Lin-Lin
    Xu, Jia-Wen
    Li, Zhi-Wei
    Shi, Peng
    Jiang, Rui
    CELL TRANSPLANTATION, 2022, 31
  • [30] Loss of PBRM1 expression is associated with renal cell carcinoma progression
    Pawlowski, Rafal
    Muehl, Sarah M.
    Sulser, Tullio
    Krek, Wilhelm
    Moch, Holger
    Schraml, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : E11 - E17